Alaunos Therapeutics, Inc. — All Filings
1,005 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10SB12G
10SB12G/A
144
3
3/A
4
4/A
424B3
424B5
424B7
424B8
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFC14A
DFAN14A
DFRN14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PREC14A
PRER14A
PRRN14A
REGDEX
S-1
S-3
S-3/A
S-3ASR
S-3MEF
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13D/A | — | 0002094682-26-000002 | Mar 5, 2026 | — |
| 8-K | 8-K | 0001193125-26-084084 | Mar 2, 2026 | — |
| SCHEDULE 13D/A | — | 0002094682-26-000001 | Feb 24, 2026 | — |
| 4 | 4 | 0001193125-26-014115 | Jan 15, 2026 | Jan 12, 2026 |
| 4 | 4 | 0001193125-26-014116 | Jan 15, 2026 | Jan 12, 2026 |
| 4 | 4 | 0001193125-26-014117 | Jan 15, 2026 | Jan 12, 2026 |
| 8-K | 8-K | 0001193125-26-007054 | Jan 8, 2026 | — |
| 8-K | 8-K | 0001193125-25-331147 | Dec 23, 2025 | Dec 17, 2025 |
| 424B8 | 424B8 | 0001193125-25-316216 | Dec 11, 2025 | — |
| SCHEDULE 13D/A | — | 0002094682-25-000003 | Dec 5, 2025 | — |
| 4 | 4 | 0001193125-25-301033 | Nov 26, 2025 | Nov 21, 2025 |
| 4 | 4 | 0001193125-25-301025 | Nov 26, 2025 | Nov 21, 2025 |
| 4 | 4 | 0001193125-25-301026 | Nov 26, 2025 | Nov 21, 2025 |
| 10-Q | 10-Q | 0001193125-25-282988 | Nov 14, 2025 | Sep 30, 2025 |
| S-3/A | S-3/A | 0001193125-25-272465 | Nov 7, 2025 | — |
| SCHEDULE 13D/A | — | 0002094682-25-000002 | Oct 31, 2025 | — |
| SCHEDULE 13D | — | 0002094682-25-000001 | Oct 30, 2025 | — |
| S-1 | S-1 | 0001193125-25-245483 | Oct 22, 2025 | — |
| SCHEDULE 13G/A | — | 0001213900-25-099624 | Oct 16, 2025 | — |
| S-3/A | S-3/A | 0001193125-25-227248 | Oct 2, 2025 | — |
| S-3/A | S-3/A | 0001193125-25-198562 | Sep 9, 2025 | — |
| SCHEDULE 13D/A | — | 0001213900-25-085149 | Sep 5, 2025 | — |
| SCHEDULE 13G | — | 0001213900-25-084258 | Sep 4, 2025 | — |
| S-3 | S-3 | 0001193125-25-184432 | Aug 21, 2025 | — |
| 4 | 4 | 0000950170-25-110531 | Aug 20, 2025 | Aug 18, 2025 |
| 4 | 4 | 0000950170-25-110530 | Aug 20, 2025 | Aug 18, 2025 |
| 8-K | 8-K | 0000950170-25-110484 | Aug 20, 2025 | Aug 19, 2025 |
| 10-Q | 10-Q | 0000950170-25-108887 | Aug 14, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-097591 | Jul 22, 2025 | Jul 16, 2025 |
| 3 | 3 | 0000950170-25-096673 | Jul 17, 2025 | Jul 15, 2025 |
| 8-K | 8-K | 0000950170-25-096656 | Jul 17, 2025 | Jul 15, 2025 |
| 4 | 4 | 0000950170-25-096674 | Jul 17, 2025 | Jul 15, 2025 |
| 8-K | 8-K | 0000950170-25-095029 | Jul 10, 2025 | Jul 3, 2025 |
| 4 | 4 | 0000950170-25-094386 | Jul 7, 2025 | Jul 3, 2025 |
| 4 | 4 | 0000950170-25-094387 | Jul 7, 2025 | Jul 3, 2025 |
| 4 | 4 | 0000950170-25-094383 | Jul 7, 2025 | Jul 2, 2025 |
| 8-K | 8-K | 0000950170-25-093263 | Jul 2, 2025 | Jul 1, 2025 |
| SCHEDULE 13D | — | 0000921895-25-001912 | Jul 1, 2025 | — |
| 4 | 4 | 0000950170-25-090589 | Jun 26, 2025 | Jun 24, 2025 |
| 4 | 4 | 0000950170-25-090587 | Jun 26, 2025 | Jun 24, 2025 |
| 8-K | 8-K | 0000950170-25-090201 | Jun 26, 2025 | Jun 24, 2025 |
| 8-K | 8-K | 0000950170-25-090202 | Jun 26, 2025 | Jun 20, 2025 |
| 424B3 | 424B3 | 0001193125-25-145739 | Jun 24, 2025 | — |
| 8-K | 8-K | 0000950170-25-083913 | Jun 10, 2025 | Jun 9, 2025 |
| 8-K | 8-K | 0000950170-25-077064 | May 23, 2025 | May 19, 2025 |
| DEF 14A | DEF 14A | 0001193125-25-123677 | May 21, 2025 | Jul 3, 2025 |
| ARS | ARS | 0001193125-25-123682 | May 21, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA14A | 0001193125-25-123680 | May 21, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-072709 | May 15, 2025 | Mar 31, 2025 |
| SCHEDULE 13D | — | 0001213900-25-043211 | May 14, 2025 | — |